PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA AND RELATED DISORDERS
申请人:JENKINS Helen
公开号:US20100160351A1
公开(公告)日:2010-06-24
Disclosed is a pharmaceutical composition comprising (a) a first therapeutic agent, wherein the first therapeutic agent is a compound of formula II:
or a pharmaceutically acceptable salt thereof, wherein R
1
, R
2
, R
3
, R
4
, X and n are as defined herein; (b) a second therapeutic agent, wherein the second therapeutic agent is a uric acid synthesis inhibitor or a uricosuric agent; and (c) a pharmaceutically acceptable diluent or carrier.